Interferon-β treatment of experimental autoimmune encephalomyelitis leads to rapid nonapoptotic termination of T cell infiltration

Journal of Neuroscience Research

Volumn 65, Issue 1, 2001, Pages 59-67

  Schmidt, Jens ^a   Stürzebecher, Steffen ^b   Toyka, Klaus Viktor ^a   Gold, Ralf ^a,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b BAYER PHARMA AG   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Autoimmune disorders; Central nervous system; Inflammation; Interferons; T cell apoptosis

Indexed keywords

ALBUMIN; BETA INTERFERON; CYTOKINE; GELATINASE A; METHYLPREDNISOLONE; RECOMBINANT BETA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; T LYMPHOCYTE;

EID: 0034951492     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.1128     Document Type: Article

References (33)

1. IFN-alpha and IFN-beta: A link between immune memory and chronic inflammation
2. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway
3. Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis
4. Effect of steroids on Gd-enhancing lesions before and during recombinant beta interferon la treatment in relapsing remitting multiple sclerosis
5. Interferon beta-1b treatment modulates TNFalpha and IFNgamma spontaneous gene expression in MS
6. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques
7. T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR beta-chain-variable-region V beta 8.2-positive T cells are not essential for induction and course of disease
8. Animal models for autoimmune demyelinating disorders of the nervous system
9. Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives
10. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
11. Virus interference: I. The interferon
12. Intrathecal interferon reduces exacerbations of multiple sclerosis
13. Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1
14. Interferon-beta 1b augments activation-induced T-cell death in multiple sclerosis patients
15. Induction of Fas ligand-mediated apoptosis by interferon-alpha
16. Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer
17. In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema
18. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial
19. Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients
20. The Effects of interferon-β on cytokines and immune responses
21. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS
22. The length of treatment determines whether IFN-beta prevents or aggravates experimental auto-immune encephalomyelitis in Lewis rats
23. T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy
24. Interferon beta-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9
25. Discontinuation of treatment with IFN-beta leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-beta and excessive expansion of autoreactive T cells as disease promoting mechanisms
26. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
27. Interferon beta in the treatment of multiple sclerosis: Mechanisms of action
28. Matrix metalloproteinases and diseases of the CNS
29. Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis
30. Intravenous glucocorticosteroid treatment augments apoptosis of inflammatory T cells in experimental autoimmune neuritis (EAN) of the Lewis rat
31. Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis
32. No induction of apoptosis by IFN-beta in human antigen-specific T cells